These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24802839)

  • 21. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load.
    Kira J; Nakamura M; Sawada T; Koyanagi Y; Ohori N; Itoyama Y; Yamamoto N; Sakaki Y; Goto I
    J Neurol Sci; 1992 Jan; 107(1):98-104. PubMed ID: 1578240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S
    Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lessons from the Cerebrospinal Fluid Analysis of HTLV-1-Infected Individuals: Biomarkers of Inflammation for HAM/TSP Development.
    Freitas NL; Gomes YCP; Souza FDS; Torres RC; Echevarria-Lima J; Leite ACCB; Lima MASD; Araújo AQC; Silva MTT; Espíndola OM
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of association between single-nucleotide polymorphisms of pro- and anti-inflammatory cytokines and HTLV-1-associated myelopathy / tropical spastic paraparesis development in patients from Rio de Janeiro, Brazil.
    Schor D; Porto LC; Roma EH; Quintana MSB; Fabricio-Silva GM; Bonecini-Almeida MG; Araújo AQ; Andrada-Serpa MJ
    BMC Infect Dis; 2018 Nov; 18(1):593. PubMed ID: 30466392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Saito M; Tanaka R; Arishima S; Matsuzaki T; Ishihara S; Tokashiki T; Ohya Y; Takashima H; Umehara F; Izumo S; Tanaka Y
    Retrovirology; 2013 May; 10():51. PubMed ID: 23651542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease.
    Furtado Mdos S; Andrade RG; Romanelli LC; Ribeiro MA; Ribas JG; Torres EB; Barbosa-Stancioli EF; Proietti AB; Martins ML
    J Med Virol; 2012 Apr; 84(4):664-71. PubMed ID: 22337307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica.
    Krämer A; Maloney EM; Morgan OS; Rodgers-Johnson P; Manns A; Murphy EL; Larsen S; Cranston B; Murphy J; Benichou J
    Am J Epidemiol; 1995 Dec; 142(11):1212-20. PubMed ID: 7485068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
    Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal trends in Human T-Lymphotropic virus 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP) incidence in Martinique over 25 years (1986-2010).
    Olindo S; Jeannin S; Saint-Vil M; Signate A; Edimonana-Kaptue M; Joux J; Merle H; Richard P; Granjeaud S; Cabre P; Smadja D; Cesaire R; Lezin A
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006304. PubMed ID: 29554087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad.
    Maloney EM; Cleghorn FR; Morgan OS; Rodgers-Johnson P; Cranston B; Jack N; Blattner WA; Bartholomew C; Manns A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):167-70. PubMed ID: 9473019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nagasaka M; Yamagishi M; Yagishita N; Araya N; Kobayashi S; Makiyama J; Kubokawa M; Yamauchi J; Hasegawa D; Coler-Reilly ALG; Tsutsumi S; Uemura Y; Arai A; Takata A; Inoue E; Hasegawa Y; Watanabe T; Suzuki Y; Uchimaru K; Sato T; Yamano Y
    Proc Natl Acad Sci U S A; 2020 May; 117(21):11685-11691. PubMed ID: 32393644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tropical spastic paraparesis/HTLV-I-associated myelopathy in Europe and in Africa: clinical and epidemiologic aspects.
    Touzé E; Gessain A; Lyon-Caen O; Gout O
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S38-45. PubMed ID: 8797702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
    Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
    Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal lesions and widespread involvement of white matter associated with multi-organ inflammatory disease in human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Mendes GB; Kalil RS; Rosadas C; de Freitas MR; Puccioni-Sohler M
    Int J Infect Dis; 2014 Aug; 25():1-3. PubMed ID: 24815740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1.
    Primo J; Siqueira I; Nascimento MC; Oliveira MF; Farre L; Carvalho EM; Bittencourt AL
    Braz J Med Biol Res; 2009 Aug; 42(8):761-4. PubMed ID: 19578703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Enose-Akahata Y; Jacobson S
    Retrovirology; 2019 Nov; 16(1):35. PubMed ID: 31783764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clustering of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH) in Salvador, Bahia, Brazil.
    da Silva JL; Primo JR; de Oliveira Mde F; Batista Eda S; Moreno-Carvalho O; Farré L; Bittencourt AL
    J Clin Virol; 2013 Oct; 58(2):482-5. PubMed ID: 23932323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Balance Impairments in Patients with Human T-Cell Lymphotropic Virus Type 1 Infection.
    Vasconcelos BHB; Callegari B; Costa KHA; Barroso TGCP; Sousa RCM; Saunier G; Xavier MB; Souza GS
    Sci Rep; 2019 Aug; 9(1):11456. PubMed ID: 31391511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan.
    Tsutsumi S; Sato T; Yagishita N; Yamauchi J; Araya N; Hasegawa D; Nagasaka M; Coler-Reilly ALG; Inoue E; Takata A; Yamano Y
    Orphanet J Rare Dis; 2019 Oct; 14(1):227. PubMed ID: 31639014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.
    Kaplan JE; Osame M; Kubota H; Igata A; Nishitani H; Maeda Y; Khabbaz RF; Janssen RS
    J Acquir Immune Defic Syndr (1988); 1990; 3(11):1096-101. PubMed ID: 2213510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.